Literature DB >> 23244290

Cortico-basal ganglia and cortico-cerebellar circuits in Parkinson's disease: pathophysiology or compensation?

Kristina Martinu1, Oury Monchi.   

Abstract

The basal ganglia and the cerebellum are anatomically and functionally linked to the cerebral cortex through a series of well-established circuits. The disruption of dopaminergic projections in Parkinson's disease (PD) leads to an imbalance within these circuits, leading to motor and cognitive symptoms. The cortico-cerebellar (CC) network has often been viewed as a compensatory network, helping the dysfunction of the cortico-basal ganglia (CBG) circuits in PD. However, evidence for this compensatory role is scarce; most changes in cerebellar activity could equally be attributed to pathophysiological changes underlying PD. This paper will review the anatomy, interaction and function of the CBG and CC circuits, the pathophysiological, metabolic, and functional changes observed in PD, as well as the effect of levodopa and deep brain stimulation on these changes. We will use this framework to discuss the pathophysiological and compensatory mechanisms behind CBG and CC circuit activity in PD.

Entities:  

Mesh:

Year:  2012        PMID: 23244290     DOI: 10.1037/a0031226

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  25 in total

1.  Manganese and neurobehavioral impairment. A preliminary risk assessment.

Authors:  Robert M Park; Shannon L Berg
Journal:  Neurotoxicology       Date:  2017-08-10       Impact factor: 4.294

2.  Global Functional Network Connectivity Disturbances in Parkinson's Disease with Mild Cognitive Impairment by Resting-State Functional MRI.

Authors:  Xin-Xin Shuai; Xiang-Chuang Kong; Yan Zou; Si-Qi Wang; Yu-Hui Wang
Journal:  Curr Med Sci       Date:  2021-01-11

3.  Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease.

Authors:  Alice Cronin-Golomb
Journal:  Behav Neurosci       Date:  2013-04       Impact factor: 1.912

4.  Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease.

Authors:  Eva M Müller-Oehring; Edith V Sullivan; Adolf Pfefferbaum; Neng C Huang; Kathleen L Poston; Helen M Bronte-Stewart; Tilman Schulte
Journal:  Brain Imaging Behav       Date:  2015-09       Impact factor: 3.978

Review 5.  The basal ganglia and the cerebellum: nodes in an integrated network.

Authors:  Andreea C Bostan; Peter L Strick
Journal:  Nat Rev Neurosci       Date:  2018-06       Impact factor: 34.870

6.  Rhythmic auditory cues shape neural network recruitment in Parkinson's disease during repetitive motor behavior.

Authors:  Kurt Braunlich; Carol A Seger; Kade G Jentink; Isabelle Buard; Benzi M Kluger; Michael H Thaut
Journal:  Eur J Neurosci       Date:  2018-12-03       Impact factor: 3.386

7.  The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.

Authors:  Olivia M Farr; Sien Hu; David Matuskey; Sheng Zhang; Osama Abdelghany; Chiang-Shan R Li
Journal:  Exp Clin Psychopharmacol       Date:  2013-11-04       Impact factor: 3.157

8.  Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication.

Authors:  Sara B Festini; Jessica A Bernard; Youngbin Kwak; Scott Peltier; Nicolaas I Bohnen; Martijn L T M Müller; Praveen Dayalu; Rachael D Seidler
Journal:  Front Hum Neurosci       Date:  2015-04-21       Impact factor: 3.169

9.  Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease.

Authors:  Lior Greenbaum; Mordechai Lorberboym; Eldad Melamed; Amihai Rigbi; Yael Barhum; Yoav Kohn; Alexander Khlebtovsky; Bernard Lerer; Ruth Djaldetti
Journal:  Front Neurosci       Date:  2013-04-15       Impact factor: 4.677

10.  Compensatory striatal-cerebellar connectivity in mild-moderate Parkinson's disease.

Authors:  Alison C Simioni; Alain Dagher; Lesley K Fellows
Journal:  Neuroimage Clin       Date:  2015-11-11       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.